参考文献/References:
[1] Warhurg O.On the origin of cancer cells. Sciene,1956, 123(3191):309-314.
[2] Gillies RJ, Robcy I, Gatenby RA. Gauses and consequences of increased glucose metabolism of cancers. J Nucl Med, 2008, 49(Suppl 2):24S-42S.
[3] Gambhir SS, Gzernin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med, 2001, 42(5 Supp):1S-93S.
[4] 孟晓云,陈跃.葡萄糖转运蛋自的调控与疾病.医学综述,2008, 14(14):2097-2100.
[5] 赵迎超,伍钢.已糖激酶与恶性肿瘤关系的研究进展.肿瘤防治研究,2006,33(9):694-696.
[6] Rho M, Kim J, Jee CD, et al. Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines. Anticancer Res, 2007, 27(1A):251-258.
[7] Hervouet E, Godinot C. Mitochondrial disorders in renal tumors. Mitochondrion, 2006, 6(3):105-117.
[8] Lóipez-Rios F, Sáinchez-Aragó M, García-García E,et al. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Res, 2007, 67(19):9013-9017.
[9] Isidoro A, Casado E, Redondo A, et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis, 2005, 26(12):2095-2104
[10] Zhang H, Gao P, Fukuda R, et al. HIF-1 inhibits mitochondrial bio-genesis and cellular respiration in VHL-deficient renal cell carci-noma by repression of C-MYC activity. Cancer Cell, 2007, 11(5):407-420.
[11] Krocmcr G.Mitochondria in cancer. Oncogene,2006, 25(34):4630-4632.
[12] Mazurc NM, Chauvet C, Bois-Joyeux B,et al. Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells:characterization of a negative hypoxia response ele-ment that mediates opposite effects of hypoxia inducible factor-1 and c-Myc·Cancer Res, 2002, 62(4):1158-1165.
[13] Kim JW, Gao P, Liu YC,et al. Hypoxia-inducible factor 1 and dys-regulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydro-genase kinase 1. Mol Cell Biol, 2007, 27(21):7381-7393.
[14] Benassi B, Fanciulli M, Fiorentino F,et al. C-Myc phosphorylation is required for cellular response to oxidative stress. Mol Cell, 2006, 21(4):509-519.
[15] Osthus RC, Shim H, Kim S,et al. Deregulation of glucose trans-porter 1 and glycolytic gene expression by c-Myc.J Biol Chem, 2000, 275(29):21797-21800.
[16] 杨盛力,张万广,陈孝平,等.缺氧诱导因子-1与缺氧诱导因子-2同肿瘤关系的比较.肝胆外科杂志,2007, 15(6):471-474.
[17] Levine DA, Bogomolniy F, Yee CJ,et al. Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res, 2005, 11(8):2875-2878.
[18] Knobbe CB, Tramps-Kieslich A, Reifenberger G. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas. Neuropathol Appl Neurobiol, 2005, 31(5):486-490.
[19] Oda K, Stokoe D, Taketani Y,et al. High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. Cancer Res, 2005, 65(23):10669-10673.
[20] Hartmann W,Digon-Sontgerath B, Koch A,et al. Phosphatidylinos-itol 3’-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN. Clin Cancer Res,2006, 12(10):3019-3027.
[21] Or YY, Hui AB, Tam KY,et al. Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines. Int J Oncol, 2005, 26(1):49-56.
[22] Nyakern M, Tazzari PL, Finelli C, et al. Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients. Leukemia, 2006, 20(2):230-238.
[23] Li J, Simpson L, Takahashi M, et al. The PTEN/MMAC1 tumor sup-pressor induces cell death that is rescued by the AKT protein kinase B oncogene.Cancer:Res, 1998, 58(24):5667-5672.
[24] Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell, 2000, 100(4):387-390.
[25] Buzzai M, Bauer DE, Jones RG,et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene,2005, 24(26):4165-4173.
[26] Vivanco,I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer, 2002, 2(7):489-501.
[27] Matoba S, Kung JG, Patino WD, et al. p53 regulate、mitochondrial respiration. Science,2006, 312(5780):1650-1653.
[28] Bensaad K, Vousden KH. p53:new roles in metabolism. Trends Cell Biol, 2007, 17(6):286-291.
[29] Bensaad K, Tsuruta A, Sclak MA,et al. TIGAR,a p53-inducible regulator of glycolysis and apoptosis. Cell, 2006, 126(1):107-120.
[30] Green DR, Chipuk JE. p53 and metabolism:Inside the TIGAR. Cell, 2006, 126(1):30-32.
相似文献/References:
[1]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[2]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[3]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[4]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[5]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[6]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[7]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[8]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[9]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[10]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]